Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Beyondspring Pharmaceuticals Inc.

Clinical trials sponsored by Beyondspring Pharmaceuticals Inc., explained in plain language.

BeyondSpring Pharmaceuticals Inc. BYSI NASDAQ

A clinical-stage biopharmaceutical company developing cancer therapies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 1 Completed 1

New hope for tough lung cancers: experimental combo targets resistant tumors

Disease control Not yet recruiting

This study tests whether adding the experimental drug plinabulin to standard chemotherapy (docetaxel) helps people with advanced non-squamous lung cancer live longer. It includes about 442 adults whose cancer has worsened despite prior immunotherapy and platinum chemo. Participan…

Phase: PHASE3 • Sponsor: BeyondSpring Pharmaceuticals Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:13 UTC